http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0700390-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6511f763baaf6666499a917f8b7ef221 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-54 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-54 |
| filingDate | 1994-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b43555a1cfef915587c5a76307c5d570 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c95df600972e963a06ec0f3f24cc16ec |
| publicationDate | 1996-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0700390-A1 |
| titleOfInvention | Intermediates and methods for the synthesis of anthrapyrazolone anticancer agents |
| abstract | This invention relates to compounds, including 5-chloro-2-[2-[[(4-methylphenyl)sulfonyl]oxy]ethyl]-7-[2,4,6-trimethylphenyl)methoxy]anthra[1,9-cd]pyrazol-6(2H)-one and analogs thereof, which are useful as intermediates for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone. This invention also relates to methods for the synthesis of anthrapyrazolone anticancer agents, including losoxantrone. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9260759-B2 |
| priorityDate | 1993-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.